Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 85

Using magnesium to protect the brain after cardiac arrest

Official title: Neuroprotection Following Cardiac Arrest: A Randomized Control Trial of Magnesium

Run by NYU Langone Health · NCT06455514 · Data updated 2026-11-12

This study is testing if giving magnesium to people who have survived a cardiac arrest can help protect their brain and reduce injury.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment178 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMarch 25, 2025
Main results expectedMarch 30, 2026
Study endsJune 30, 2026
Registry record updatedApril 7, 2026
Trial IDNCT06455514 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 85 who have achieved ROSC within 2 hours of cardiac arrest.

Probably not a fit

Patients with traumatic cardiac arrests or those who are expected to have life support withdrawn within 72 hours may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional study aims to evaluate the safety and feasibility of administering magnesium sulfate as a neuroprotective treatment in patients who have achieved Return of Spontaneous Circulation (ROSC) following cardiac arrest. The study will measure serum markers of neuronal injury at specific time points after ROSC to gather preliminary data. With a limited sample size, the primary goal is to assess the precision and stability of these measures to inform future larger trials.

Why it matters

Potential benefit: If successful, this approach could improve neurological outcomes for patients who survive cardiac arrest.

How similar studies have gone: While this approach is novel, similar studies exploring neuroprotection after cardiac arrest have shown promise, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documented post-cardiac arrest patient with Return of Spontaneous Circulation (ROSC) achieved \<2 hours prior to recruitment

Exclusion Criteria:

* Age \< 18 years or \> 85 years
* Traumatic cardiac arrests
* Unsustained ROSC (\<20 minutes)
* Patient who is responsive/able to follow motor commands within 1 hour of achieving ROSC
* Plan for withdrawal of life support within 72 hours of ROSC
* Known pregnant women at the time of the cardiac arrest
* Known prisoners at the time of the cardiac arrest
* Subjects who have a medical o social condition that would make them inappropriate for the study based on the PI's or clinical team judgement.

Where it's running

  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.